scholarly article | Q13442814 |
P2093 | author name string | Wu J | |
Nguyen M | |||
Shao ZM | |||
Shen ZZ | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | 2222-2227 | |
P577 | publication date | 2001-08-01 | |
P1433 | published in | Clinical Cancer Research | Q332253 |
P1476 | title | p53 mutation in plasma DNA and its prognostic value in breast cancer patients | |
P478 | volume | 7 |
Q36778016 | An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma |
Q36393312 | Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients |
Q37690204 | Circulating nucleic acids as biomarkers in breast cancer |
Q37164447 | Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls |
Q46790581 | Free circulating tumor DNA as a diagnostic marker for breast cancer. |
Q81228599 | Levels of VEGF-A mRNA in plasma from patients with colorectal carcinoma as possible surrogate marker of angiogenesis |
Q26741204 | Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers |
Q33320177 | Modeling cancer progression via pathway dependencies |
Q40483796 | Multiplexed Elimination of Wild-Type DNA and High-Resolution Melting Prior to Targeted Resequencing of Liquid Biopsies |
Q33790229 | Plasma cell-free DNA in ovarian cancer: an independent prognostic biomarker |
Q35670356 | Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients |
Q35810123 | Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature |
Q59233182 | Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer |
Q24802349 | The p53 pathway in breast cancer |
Q34668320 | The prognostic molecular markers in hepatocellular carcinoma |
Q52622918 | The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis. |
Q55252785 | Tumour Markers: Rationale Use. |
Q35790070 | Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma |
Search more.